Akebia Ther Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Akebia Ther Stock Summary

Akebia Ther competes with Protalix Biotherapeutics, Cidara Therapeutics, X4 Pharmaceuticals, Seres Therapeutics, and Ocean Biomedical. Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Akebia Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 426 people.

Akebia Ther Key Financial Ratios

Akebia Ther Key Balance Sheet Accounts

Akebia Ther Key Income Statement Accounts

Akebia Ther Key Cash Accounts

Akebia Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Akebia Ther's current stock value. Our valuation model uses many indicators to compare Akebia Ther value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Akebia Ther competition to find correlations between indicators driving Akebia Ther's intrinsic value. More Info.Akebia Ther is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers . At present, Akebia Ther's Return On Equity is projected to drop slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akebia Ther's earnings, one of the primary drivers of an investment's value.

Akebia Ther Systematic Risk

Today, most investors in Akebia Ther Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Akebia Ther's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Akebia Ther growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Akebia Ther help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Akebia Ther. We use our internally-developed statistical techniques to arrive at the intrinsic value of Akebia Ther based on widely used predictive technical indicators. In general, we focus on analyzing Akebia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Akebia Ther's daily price indicators and compare them against related drivers.

When running Akebia Ther's price analysis, check to measure Akebia Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Ther is operating at the current time. Most of Akebia Ther's value examination focuses on studying past and present price action to predict the probability of Akebia Ther's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Ther's price. Additionally, you may evaluate how the addition of Akebia Ther to your portfolios can decrease your overall portfolio volatility.